Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000904454-11-000619)

Filing Details

Accession Number:: 0000904454-11-000619
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-11-21 20:27:19
Reporting Period:: 2011-11-21

Filing Date:: 2011-11-21
Accepted Time:: 2011-11-21 20:27:19
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1466301	Clovis Oncology Inc.	CLVS	Pharmaceutical Preparations (2834)	900475355

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1374150	P L Vii Parters Domain	C/O Domain Associates, Llc One Palmer Square Princeton NJ 08542		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-11-21	409,192	$0.00	409,192	No	4	C	Direct
Common Stiock	Acquisiton	2011-11-21	409,192	$0.00	818,384	No	4	C	Direct
Common Stock	Acquisiton	2011-11-21	885,696	$0.00	1,704,080	No	4	C	Direct
Common Stock	Acquisiton	2011-11-21	370,799	$0.00	2,074,879	No	4	C	Direct
Common Stock	Acquisiton	2011-11-21	916,058	$13.00	2,990,937	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A-1 Preferred Stock	Disposition	2011-11-21	1,186,657	$0.00	409,192	$0.00
Common Stock	Series A-2 Preferred Stock	Disposition	2011-11-21	1,186,657	$0.00	409,192	$0.00
Common Stock	Series B Preferred Stok	Disposition	2011-11-21	2,568,521	$0.00	885,696	$0.00
Common Stock	Convertible Promissory Note	Disposition	2011-11-21	0	$0.00	370,799	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct
0			No	4	C	Direct
0			No	4	C	Direct
0			No	4	C	Direct

Footnotes

All outstanding shares of the Issuer's preferred stock were automatically converted into Common Stock upon the closing of the Issuer's iniital public offering (the "IPO"), for no additional consideration.
The Convertible Promissory Note plus interest accrued thereon through the closing of the IPO, automatically converted into Common Stock upon the closing of the IPO, based on the IPO price of $13.00 per share.